Dmk Pharmaceuticals Corporation Receivables Turnover Ratio (DMK), from the third quarter 2023 to the third quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Dmk Pharmaceuticals Corporation  (NASDAQ: DMK)
 

Dmk Pharmaceuticals Accounts Receivables Turnover Ratio from the third quarter 2023 to the third quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Dmk Pharmaceuticals Corporation's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2023 to a ratio of 12.53, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2023. Average receivable collection period, for the Dmk Pharmaceuticals in Sep 30 2023 quarter, has decreased to 29 days, compared to 49 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 318 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 691 to 2326.

What is Receivable Turnover Ratio?
What is Dmk Pharmaceuticals Corporation Selling?


What is Receivable Turnover Ratio?





DMK Receivables Turnover Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Receivable Change - -98.02 % -99.54 % -81.61 % -78.1 %
Y / Y Revenue Change -99.4 % -82.57 % 25.85 % - 98.13 %
Receivable Turnover Ratio (TTM) 12.53 7.5 5.59 2.32 0.47
DMK's Total Ranking # 2326 # 691 # 891 # 924 # 0
Accounts Receivable average collection period days 29 49 65 157 771
Seq. Receivable Change - -10.4 % -98.05 % -30.18 % 62.54 %
Seq. Revenue Change 30.48 % -99.52 % -29.33 % 36.55 % 3678.66 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 95
Healthcare Sector # 319
Overall Market # 2326

Receivable Turnover Ratio Statistics
High Average Low
0.54 0.28 -0.16
(Jun 30 2023)   (Sep 30 2022)






Financial Statements
Dmk Pharmaceuticals's Accounts Receivable $ 0 Millions Visit DMK's Balance sheet
Dmk Pharmaceuticals's Sales TTM $ 4 Millions Visit DMK's Income Statement
Sources of DMK's Revenues Visit DMK's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DMK's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DMK's Growth Rates DMK's Roa DMK's Inventory Turnover Ratio DMK's Dividend Comparisons
DMK's Profitability Ratios DMK's Roi DMK's Asset Turnover Ratio DMK's Dividend Growth
DMK's Valuation Ratios DMK's Roe DMK's Financial Strength Ratios DMK's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Receivable at quarter ending Sep 30 2023

Date modified: 2026-08-29T17:18:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.